Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are four patents protecting this drug. This drug has thirty-six…
The post New patent for Biocryst drug ORLADEYO appeared first on DrugPatentWatch - Make Better Decisions.